BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1665350)

  • 21. Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.
    Santucci MA; Zaccaria A; Testoni N; Russo D; Zuffa E; Baccarani M; Tura S
    Haematologica; 1991; 76(5):357-62. PubMed ID: 1806437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

  • 23. Culture purging in leukemia: past, present, and future.
    Eaves AC; Eaves CJ; Phillips GL; Barnett MJ
    Leuk Lymphoma; 1993; 11 Suppl 1():259-63. PubMed ID: 8251907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia.
    Dunbar CE; Stewart FM
    Blood; 1992 Mar; 79(5):1107-10. PubMed ID: 1536939
    [No Abstract]   [Full Text] [Related]  

  • 25. [Autologous bone marrow transplantation for CML].
    Nagamura F; Nagamura-Inoue T
    Nihon Rinsho; 2001 Dec; 59(12):2369-74. PubMed ID: 11766341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion and activation of human natural killer cells for autologous therapy.
    Miller JS; Verfaillie C; McGlave P
    J Hematother; 1994; 3(1):71-4. PubMed ID: 7922011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bone marrow transplantation].
    Miyamura K; Morishima Y
    Rinsho Byori; 1991 Jul; Suppl 90():23-34. PubMed ID: 1920852
    [No Abstract]   [Full Text] [Related]  

  • 29. Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction.
    Bieva C; Martiat P; Ferster A; Sariban E; Kedar A; Erdos G; Bron D; Debusscher L; Stryckmans P
    Prog Clin Biol Res; 1992; 377():197-204. PubMed ID: 1438416
    [No Abstract]   [Full Text] [Related]  

  • 30. Autologous transplant for CML revisited.
    Daley GQ; Goldman JM
    Exp Hematol; 1993 Jun; 21(6):734-7. PubMed ID: 8500574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients).
    Hum Gene Ther; 1993 Dec; 4(6):821-34. PubMed ID: 8186294
    [No Abstract]   [Full Text] [Related]  

  • 32. Autologous stem cell transplantation in chronic myeloid leukemia.
    Olavarria E
    Semin Hematol; 2007 Oct; 44(4):252-8. PubMed ID: 17961724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular transplantation in acute hepatic failure and targeting genetic markers to hepatic cells.
    Ledley FD; Woo SL; Ferry GD; Whisennand HH; Brandt ML; Darlington GJ; Demmler GJ; Finegold MJ; Pokorny WJ; Rosenblatt H
    Hum Gene Ther; 1991; 2(4):331-58. PubMed ID: 1665349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
    McGlave PB; Arthur D; Miller WJ; Lasky L; Kersey J
    Bone Marrow Transplant; 1990 Aug; 6(2):115-20. PubMed ID: 2119838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Delage R; Ritz J; Anderson KC
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):369-88. PubMed ID: 2182597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro culture of bone marrow cells for autografting in CML.
    Eaves CJ; Barnett MJ; Eaves AC
    Leukemia; 1993 Aug; 7 Suppl 2():S126-9. PubMed ID: 8361215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
    Santos GW
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.